Open-uri20160406-3-16gdoks_thumb

Michelle Pflumm

Independent Scientific Editor and Writer

Boston, MA

Michelle Pflumm

I bring science to life in multimedia and the written word.

Featured

Open-uri20190102-4-1l3rhhf_profile

Identifying Environmental Risk Factors in ALS: Take Two?

To identify environmental risk factors, scientists may need to study inherited cases of ALS.
ALS Research Forum Link to Story
Open-uri20190108-4-nx7z76_profile

Traffic Tie-up May Lead to ALS, Scientists Say

Key changes in KIF5A are linked to ALS, a protein that helps transport mitochondria along axons.
ALS Research Forum Link to Story
Open-uri20190102-4-kqtive_profile

To Reduce Trial Size Use Muscle, ALS Scientists Say

A simple blood test may help scientists detect potential treatment effects in a smaller sample size.
ALS Research Forum Link to Story
Open-uri20190102-4-1kqfwlt_profile

Scientists Go for the Gut in ALS

A new study aims to determine whether key microbial changes in the gut may be associated with ALS.
ALS Research Forum Link to Story
Open-uri20160404-3-vl6wz4_profile

ALS Trial Nears T Off

Low dose IL-2 aims to slow progression of ALS by reducing inflammation.
ALS Today Link to Story
Open-uri20160404-3-so6d08_profile

Weighing in on the high fat diet in ALS

Certain calorie rich diets appear to be safe in people with ALS. But are they of benefit?
ALS Today Link to Story
Open-uri20160404-3-1ytufkt_profile

Antisense and ALS sensibility

Could small molecules be a better approach to tackle C9orf72 ALS? Experts weigh in.
ALS Today Link to Story
Open-uri20160404-3-65vn7a_profile

Breaking the ultrasound barrier in ALS

Checkups may become easier for people with ALS with NMUS, an emerging alternative to EMG.
ALS Today Link to Story
Open-uri20160404-3-38rldr_profile

ALS clinical trials, powering forward

Biogen Idec's Doug Kerr talks dex and the development of future ALS medicines going forward.
ALS Today Link to Story
Open-uri20160405-3-1iczvif_profile

iPS: ready, set, screen?

iPS cells are a promising tool for ALS drug discovery. But key challenges remain in using them.
ALS Today Link to Story
Open-uri20160404-3-16yh699_profile

Breaking the code of silence in ALS

Emerging epigenetic drugs may have the potential to treat ALS. But using them safely may be tricky.
ALS Today Link to Story
Open-uri20160404-3-gg6dug_profile

MRI, Make That A Double

Combined MRI methods aim to facilitate the diagnosis of ALS and development of new medicines.
ALS Today Link to Story

About

Michelle Pflumm

Michelle Pflumm is an independent scientific editor and writer currently focusing on the neurosciences. An experienced multimedia journalist, she has covered the latest in science and medicine for Nature Medicine, Nature Methods, the ALS Research Forum and ALS Today. A huge NPR fan, Michelle also produced two stories for WBUR’s World of Ideas. In 2010, she worked as a multimedia content developer at Children’s Hospital Boston and in 2008, as a scientific editor for Nature Methods. She holds a Ph.D. in Molecular and Cellular Biology from the University of California, Berkeley, a B.A. in Chemistry from Haverford College and a M.S. in Science and Medical Journalism from Boston University.